BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4640285)

  • 1. Pulmonary hypertension during systemic hypotension. Effects of oxygen breathing and of vasodilators.
    Bo G; Hauge A; Hognestad J
    Acta Physiol Scand; 1972 Dec; 86(4):466-73. PubMed ID: 4640285
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of bradykinin on the pulmonary veins.
    Hyman AL
    J Pharmacol Exp Ther; 1968 May; 161(1):78-87. PubMed ID: 5648503
    [No Abstract]   [Full Text] [Related]  

  • 3. [Obstructive pulmonary hypertension: effect of aminophylline, hyperventilation and O 2 respiration].
    Renggli I; Daum S
    Schweiz Med Wochenschr; 1971 Mar; 101(10):352-7. PubMed ID: 5558550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of bradykinin on general and regional hemodynamics. General and pulmonary circulation].
    Accatino G; Betti C; Dessy P; Gagna C; Uslenghi E
    Minerva Med; 1966 Sep; 57(78):3139-40. PubMed ID: 5918700
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Cardiovascular effects of dobutamine, a selective inotropic catecholamine.
    Jewitt D; Birkhead J; Mitchell A; Dollery C
    Br Heart J; 1974 Oct; 36(10):1034-5. PubMed ID: 4433436
    [No Abstract]   [Full Text] [Related]  

  • 6. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension.
    Tayama E; Ueda T; Shojima T; Akasu K; Oda T; Fukunaga S; Akashi H; Aoyagi S
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):715-9. PubMed ID: 17704123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of isoproterenol on the input impedance of human pulmonary circulation].
    Fricke G; Scheu H; Gessner U; Studer U; Hirzel H
    Verh Dtsch Ges Kreislaufforsch; 1971; 37():284-8. PubMed ID: 5140995
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of glucagon on pulmonary vascular resistance.
    Kirsh MM; Kahn DR; Lucchesi B; Gago O; Dufek JH; Lee RW; Stutz D; Sloan H
    Surgery; 1971 Sep; 70(3):439-42. PubMed ID: 5568529
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of bradykinin on total peripheral resistance and regional vascular resistance in the rat.
    Arcidiacono FG; Reininger EJ; Sapirstein LA
    Bibl Anat; 1967; 9():29-32. PubMed ID: 6029880
    [No Abstract]   [Full Text] [Related]  

  • 10. Action of bradykinin on cardiac output and blood distribution of rats.
    Takács L; Albert K
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):117-21. PubMed ID: 5319631
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactive pulmonary arterial hypertension after pulmonary venous constriction in the calf.
    Silove ED; Tavernor WD; Berry CL
    Cardiovasc Res; 1972 Jan; 6(1):36-44. PubMed ID: 5014277
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of intravenous morphine in patients with mitral valvular disease and congestive heart failure.
    Grendahl H; Andersen A; Müller C
    Acta Med Scand; 1973; 1-2(1):69-74. PubMed ID: 4727250
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
    J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Escherichia coli endotoxin on the circulation.
    Brockman SK; Thomas CS; Vasko JS
    Surg Gynecol Obstet; 1967 Oct; 125(4):763-74. PubMed ID: 4962943
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose inhalation therapy with nitric oxide and oxygen--implications for long-term application in patients with COPD and pulmonary hypertension.
    Leitner C; Ziesche R; Zimpfer M; Block LH; Germann P
    Acta Anaesthesiol Scand Suppl; 1996; 109():96-7. PubMed ID: 8901962
    [No Abstract]   [Full Text] [Related]  

  • 16. Bronchopulmonary effects of pentaerythrityl tetranitrate and isoproterenol.
    Aviado DM; Kishimoto T; Kneidinger HJ
    J Pharmacol Exp Ther; 1969 Feb; 165(2):274-85. PubMed ID: 5763062
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary and systemic vascular responses to nitrous oxide in patients with mitral stenosis and pulmonary hypertension.
    Hilgenberg JC; McCammon RL; Stoelting RK
    Anesth Analg; 1980 May; 59(5):323-6. PubMed ID: 7189378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bradykinin on the pulmonary vascular bed of the intact dog.
    DePasquale NP; Sanchez G; Burch GE; Quiroz AC
    Am Heart J; 1969 Dec; 78(6):802-6. PubMed ID: 5352994
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary allotransplantation in dogs with chronic pulmonary hypertension.
    Weedn RJ; Guenter CA; Greenfield LJ
    Surg Forum; 1970; 21():243-5. PubMed ID: 4936974
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary hypertension resulting from oxygen exposure. NADC-MR-6802.
    Schmidt CF
    NADC-MR Rep; 1968 Jun; ():1-18. PubMed ID: 5303577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.